VibroSense Dynamics markets and develops Medical Devices and Services addressing early diagnosis of peripheral sensory neuropathy, i.e. damages in nerves and nerve trunks in hands and feet. Main focus areas are Diabetes, Chemotherapy, and Occupational healthcare.
The methodology of VibroSense Meter is called Multi Frequency Vibrometry which is capable to detect and quantify sub-clinical or pre-symptomatic signs of peripheral sensory neuropathy. Multi Frequency Vibrometry is based on more than 35 years of clinical research.